Annual FCF
$113.84 M
+$163.75 M+328.07%
31 December 2023
Summary:
Evolent Health annual free cash flow is currently $113.84 million, with the most recent change of +$163.75 million (+328.07%) on 31 December 2023. During the last 3 years, it has risen by +$100.07 million (+727.06%). EVH annual FCF is now at all-time high.EVH Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
$12.38 M
-$1.93 M-13.49%
30 September 2024
Summary:
Evolent Health quarterly free cash flow is currently $12.38 million, with the most recent change of -$1.93 million (-13.49%) on 30 September 2024. Over the past year, it has dropped by -$70.95 million (-85.14%). EVH quarterly FCF is now -85.14% below its all-time high of $83.33 million, reached on 31 December 2023.EVH Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
$109.58 M
-$41.35 M-27.39%
30 September 2024
Summary:
Evolent Health TTM free cash flow is currently $109.58 million, with the most recent change of -$41.35 million (-27.39%) on 30 September 2024. Over the past year, it has dropped by -$4.25 million (-3.74%). EVH TTM FCF is now -27.39% below its all-time high of $150.93 million, reached on 30 June 2024.EVH TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EVH Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -85.1% | -3.7% |
| 3 y3 years | +727.1% | -79.2% | +696.2% |
| 5 y5 years | +245.6% | +207.2% | +240.2% |
EVH Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +328.1% | -85.1% | +118.8% | -27.4% | +319.5% |
| 5 y | 5 years | at high | +245.6% | -85.1% | +118.8% | -27.4% | +184.8% |
| alltime | all time | at high | +245.6% | -85.1% | +118.8% | -27.4% | +184.8% |
Evolent Health Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $12.38 M(-13.5%) | $109.58 M(-27.4%) |
| June 2024 | - | $14.31 M(-3367.4%) | $150.93 M(+15.7%) |
| Mar 2024 | - | -$438.00 K(-100.5%) | $130.43 M(+14.6%) |
| Dec 2023 | $113.84 M(-328.1%) | $83.33 M(+55.1%) | $113.84 M(+105.3%) |
| Sept 2023 | - | $53.73 M(-967.8%) | $55.46 M(-577.6%) |
| June 2023 | - | -$6.19 M(-63.6%) | -$11.61 M(+1069.4%) |
| Mar 2023 | - | -$17.03 M(-168.2%) | -$993.00 K(-98.0%) |
| Dec 2022 | -$49.91 M(-462.6%) | $24.95 M(-287.0%) | -$49.91 M(+223.0%) |
| Sept 2022 | - | -$13.34 M(-401.4%) | -$15.45 M(-142.7%) |
| June 2022 | - | $4.43 M(-106.7%) | $36.16 M(+1785.5%) |
| Mar 2022 | - | -$65.95 M(-211.0%) | $1.92 M(-86.1%) |
| Dec 2021 | $13.76 M(-130.1%) | $59.41 M(+55.2%) | $13.76 M(-121.4%) |
| Sept 2021 | - | $38.27 M(-228.4%) | -$64.36 M(-50.2%) |
| June 2021 | - | -$29.82 M(-44.9%) | -$129.29 M(+79.9%) |
| Mar 2021 | - | -$54.10 M(+189.2%) | -$71.86 M(+57.3%) |
| Dec 2020 | -$45.70 M(-41.5%) | -$18.71 M(-29.8%) | -$45.70 M(+99.1%) |
| Sept 2020 | - | -$26.66 M(-196.5%) | -$22.96 M(+6.6%) |
| June 2020 | - | $27.61 M(-198.8%) | -$21.53 M(-69.7%) |
| Mar 2020 | - | -$27.94 M(-793.3%) | -$70.95 M(-9.2%) |
| Dec 2019 | -$78.18 M | $4.03 M(-116.0%) | -$78.18 M(-33.5%) |
| Sept 2019 | - | -$25.23 M(+15.7%) | -$117.61 M(+49.0%) |
| June 2019 | - | -$21.81 M(-38.0%) | -$78.94 M(+29.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$35.17 M(-0.6%) | -$61.11 M(+1.5%) |
| Dec 2018 | -$60.20 M(+7.9%) | -$35.40 M(-363.3%) | -$60.20 M(+138.3%) |
| Sept 2018 | - | $13.45 M(-437.1%) | -$25.26 M(-42.3%) |
| June 2018 | - | -$3.99 M(-88.4%) | -$43.81 M(-11.2%) |
| Mar 2018 | - | -$34.26 M(+7283.2%) | -$49.32 M(-11.6%) |
| Dec 2017 | -$55.81 M(+9.3%) | -$464.00 K(-90.9%) | -$55.81 M(-31.3%) |
| Sept 2017 | - | -$5.10 M(-46.3%) | -$81.26 M(+12.7%) |
| June 2017 | - | -$9.50 M(-76.7%) | -$72.10 M(+6.6%) |
| Mar 2017 | - | -$40.74 M(+57.2%) | -$67.62 M(+32.5%) |
| Dec 2016 | -$51.04 M(+104.3%) | -$25.91 M(-738.8%) | -$51.04 M(+49.9%) |
| Sept 2016 | - | $4.06 M(-180.8%) | -$34.04 M(-28.1%) |
| June 2016 | - | -$5.02 M(-79.2%) | -$47.34 M(-3.7%) |
| Mar 2016 | - | -$24.16 M(+170.8%) | -$49.14 M(+96.7%) |
| Dec 2015 | -$24.98 M(<-9900.0%) | -$8.92 M(-3.5%) | -$24.98 M(+55.5%) |
| Sept 2015 | - | -$9.24 M(+35.4%) | -$16.06 M(+135.4%) |
| June 2015 | - | -$6.82 M(<-9900.0%) | -$6.82 M(-235.4%) |
| Mar 2015 | - | $0.00(0.0%) | $5.04 M(>+9900.0%) |
| Dec 2014 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2014 | - | $0.00(-100.0%) | $0.00(0.0%) |
| June 2014 | - | $5.04 M(-200.0%) | $0.00(-100.0%) |
| Mar 2014 | - | -$5.04 M | -$5.04 M |
| Dec 2013 | -$24.07 M | - | - |
FAQ
- What is Evolent Health annual free cash flow?
- What is the all time high annual FCF for Evolent Health?
- What is Evolent Health quarterly free cash flow?
- What is the all time high quarterly FCF for Evolent Health?
- What is Evolent Health quarterly FCF year-on-year change?
- What is Evolent Health TTM free cash flow?
- What is the all time high TTM FCF for Evolent Health?
- What is Evolent Health TTM FCF year-on-year change?
What is Evolent Health annual free cash flow?
The current annual FCF of EVH is $113.84 M
What is the all time high annual FCF for Evolent Health?
Evolent Health all-time high annual free cash flow is $113.84 M
What is Evolent Health quarterly free cash flow?
The current quarterly FCF of EVH is $12.38 M
What is the all time high quarterly FCF for Evolent Health?
Evolent Health all-time high quarterly free cash flow is $83.33 M
What is Evolent Health quarterly FCF year-on-year change?
Over the past year, EVH quarterly free cash flow has changed by -$70.95 M (-85.14%)
What is Evolent Health TTM free cash flow?
The current TTM FCF of EVH is $109.58 M
What is the all time high TTM FCF for Evolent Health?
Evolent Health all-time high TTM free cash flow is $150.93 M
What is Evolent Health TTM FCF year-on-year change?
Over the past year, EVH TTM free cash flow has changed by -$4.25 M (-3.74%)